Skip to main content

Neighbourly Pharmacy Inc(NBLY-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Neighbourly Pharmacy Inc up on Thursday (NBLY)

Automated Summaries - The Globe and Mail - Thu Mar 14, 4:01PM CDT

In today's trading, Neighbourly Pharmacy Inc shares closed at $18.54 after opening the day at $18.53. Intraday prices ranged from $18.53 to $18.56.

Shares gained 0.05% from the previous day's close of $18.53.

During the day across North America, the TSX Composite closed 0.64% at 21970.11, the S&P 500 closed -0.19% at 5165.31, the Dow Jones Industrial Average closed 0.10% at 39043.32 and the Nasdaq Composite closed -0.54% at 16177.77.

Neighbourly Pharmacy Inc traded under NBLY on the Toronto Stock Exchange (TSX).

Trading volume was 285,016 on 255 total trades, while having an average volume of 282,919 over the last 5-days.

Trading across the entire TSX saw 997 price advancers against 4,289 declines and 80 unchanged.

During the prior 52 weeks, NBLY.TO has traded as high as $23.33 (March 16,2023) and low as $12.05 (October 02,2023). Moreover, in the last 12 months, Neighbourly Pharmacy Inc's shares have dipped -18.76%, while they have boosted 10.42% year-to-date.

It announced a 0.04 dividend on October 24/23, with an November 20/23 ex-date and December 19/23 pay day.

Following today's trading, Neighbourly Pharmacy Inc has a market capitalization of $832.34 million on a float of 44,919 shares outstanding. Its annual EPS is $-0.73.

Neighbourly Pharmacy Inc is a TSX Pharmaceutical Retailers company headquartered in Toronto, CAN.

Based on 0.00 analysts, Neighbourly Pharmacy Inc gets an average recommendation of "Strong Sell" according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe